SWOG clinical trial number
SWOG-8721

A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer

Closed
Phase
II
Accrual
69%
Published
Abbreviated Title
A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer
Activated
09/01/1987
Closed
09/01/1991

Research committees

Gastrointestinal Cancer

Publication Information Expand/Collapse

1996

Phase II trial of trimetrexate in advanced esophageal cancer: A Southwest Oncology Group study.

TR Fleming;TD Brown;SW Ross;JS Macdonald Investigational New Drugs 13:363-365

1992

A phase II trial of trimetrexate in the treatment of esophageal cancer: A Southwest Oncology Group trial.

T Brown;T Fleming;C Tangen;J Macdonald ASCO 11:166(#479)

Other Clinical Trials

SWOG Clinical Trial Number
SWOG-8037

Combined Therapies for Squamous Cell Carcinoma of the Esophagus

Research Committee(s)
Gastrointestinal Cancer
Activated
02/16/1981
Closed
01/19/1984
Closed
Phase
II
Published
SWOG Clinical Trial Number
SWOG-8591(NCI Intergroup #0035)

An Evaluation of Levamisole Alone or Levamisole plus 5-Fluorouracil as Surgical Adjuvant Treatment for Resectable Adenocarcinoma of the Colon

Research Committee(s)
Gastrointestinal Cancer
Activated
01/14/1985
Closed
10/01/1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8721

A Phase II Trial of Trimetrexate in the Treatment of Esophageal Cancer

Research Committee(s)
Gastrointestinal Cancer
Activated
09/01/1987
Closed
09/01/1991
Accrual
69%
Closed
Phase
II
Published